IL6 and cyclic hematopoiesis: In patients with atherosclerosis and CH, interleukin-6 (IL-6) levels were elevated regardless of the specific driver mutation, whereas high-sensitivity C-reactive protein (hsCRP) levels were significantly increased only in those with ASXL1-CH.